Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1128 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Abbott EPI drug for cystic fibrosis gets FDA approval

CREON delayed-release capsules (pancreatic enzyme medicine) are indicated for the improving food digestion in people who cannot digest food properly because they have EPI. Abbott Global Pharmaceutical Development

Arecor, GSK sign licensing deal

The companies will work together for the development of new approaches to improve administration of several vaccines in development. As per the terms of the agreement, Arecor licenses

BSI launches Entropy Software

The web-based interface allows medical device manufacturers and pharmaceutical companies to remain compliant to complex regulatory requirements, improve business performance, and manage risk through a single-sourced solution. BSI

Biocon in talks with Bristol-Myers, Sanofi

The transaction, which could be valued at close to $1bn by potential suitors, includes a combination of upfront payments, milestone-linked payments and royalties on sales of the drug,

China Botanic Q2 net sales up

The company has generated net income of $7.08m, compared to $3.42m for the same period in 2010. China Botanic’s income from operations was $8.03m, compared to $3.4m for

FDA approves Mitsubishi cardiac Troponin test

PATHFAST cTnI-II test should be used with the PATHFAST analysis system, a chemi-luminescence immunoanalyzer that measures concentrations of emergency biomarkers from a single whole blood sample. The test